Table II.
No Supplement
|
Supplement
|
|||
---|---|---|---|---|
Characteristic* | Weighted, % |
Raw Count, n† |
Weighted, % |
Raw Count, n† |
No. of subjects | 89.3 | 1859 | 10.6 | 210 |
Age, y | ||||
75–84 | 88.9 | 1356 | 11.1 | 145 |
85–94 | 90.8 | 466 | 9.2 | 49 |
≥95 | 90.0 | 48 | 10.0 | 5 |
Sex | ||||
Male | 92.8 | 742 | 7.2 | 55 |
Female | 87.0 | 1128 | 13.0 | 144 |
Education | ||||
≤5th Grade | 87.6 | 738 | 12.4 | 95 |
>5th Grade | 90.9 | 1132 | 9.1 | 104 |
Income (2004–2005 US $) | ||||
≥$10,000 | 88.9 | 846 | 11.1 | 96 |
<$10,000 | 89.6 | 761 | 10.4 | 84 |
Living arrangements | ||||
Alone | 87.7 | 515 | 12.3 | 62 |
Not alone | 90.0 | 1355 | 10.0 | 137 |
Citizenship | ||||
Born in United States | 89.3 | 1054 | 10.7 | 104 |
Born in Mexico | 89.4 | 816 | 10.6 | 95 |
Interview language | ||||
Spanish | 90.6 | 1508 | 9.4 | 153 |
English | 85.2 | 362 | 14.8 | 46 |
Health | ||||
Poor/fair | 89.3 | 1214 | 10.7 | 144 |
Good/excellent | 89.2 | 638 | 10.8 | 55 |
ADLs | ||||
Independent | 89.2 | 1177 | 10.8 | 130 |
Dependent | 89.6 | 692 | 10.4 | 69 |
IADLs | ||||
Independent | 89.7 | 474 | 10.3 | 55 |
Dependent | 89.2 | 1396 | 10.8 | 144 |
Body mass index | ||||
Normal (<25 kg/m2) | 89.4 | 485 | 10.6 | 57 |
Obese (≥25 kg/m2) | 88.8 | 988 | 11.2 | 113 |
Cognition, MMSE score | ||||
>18 | 88.4 | 1339 | 11.6 | 160 |
≤18 | 90.4 | 399 | 9.6 | 37 |
Alcohol use | ||||
Never drank | 90.2 | 857 | 9.8 | 83 |
Ever drank | 88.8 | 1013 | 11.2 | 116 |
Antiosteoporosis medication use | ||||
No | 90.2 | 1805 | 9.8 | 178 |
Yes | 69.4 | 65 | 30.6 | 21 |
ADLs = activities of daily living; lADLs = instrumental ADLs; MMSE = Mini-Mental State Examination.
Mean (SE) number of comorbidities (range, 0–6) = 1.75 (0.03) for no supplement use; 2.1 (0.11) for supplement use.
Some raw counts do not total 2069 due to missing data.